CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

4.680

-0.090 (-1.89%)

At close: Mar 6, 2026, 4:00 PM EST

4.641

-0.039 (-0.84%)

After-hours: Mar 6, 2026, 7:40 PM EST

CytomX Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	34.19	38.05	17.17	193.65	205.53	191.86
Short-Term Investments	109.44	62.57	157.34	-	99.7	124.26
Cash & Short-Term Investments	143.63	100.62	174.51	193.65	305.23	316.12
Cash Growth	22.14%	-42.34%	-9.88%	-36.55%	-3.45%	6.74%
Accounts Receivable	1.63	3.1	3.43	35.99	0.79	0.8
Other Current Assets	3.96	3.58	5	7.47	4.29	7.1
Total Current Assets	149.22	107.31	182.94	237.1	310.3	324.01
Net Property, Plant & Equipment	6.54	10.6	16.18	21.02	25.32	29.45
Other Intangible Assets	0.47	0.58	0.73	0.88	1.02	1.17
Goodwill	0.95	0.95	0.95	0.95	0.95	0.95
Other Long-Term Assets	1.08	1.09	1	0.94	1.82	3.09
Total Assets	158.25	120.53	201.79	260.89	339.41	358.66
Accounts Payable	0.65	1.09	1.46	2.81	2.82	3
Accrued Expenses	12.41	12.34	17.6	24.45	34.24	23.06
Current Portion of Leases	5.6	5.15	4.59	4.08	-	-
Unearned Revenue	22.38	67.2	132.27	121.27	40.82	42.06
Total Current Liabilities	41.03	85.77	155.91	152.61	77.87	68.11
Long-Term Leases	-	4.24	9.39	13.98	18.06	21.68
Other Long-Term Liabilities	9.84	30.98	83.94	180.06	243.94	276.65
Total Long-Term Liabilities	9.84	35.22	93.33	194.03	262	298.33
Total Liabilities	50.87	120.99	249.24	346.64	339.87	366.44
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	789.72	691.1	675.91	637.12	623.34	499.96
Accumulated Other Comprehensive Income	0.1	0.03	0.1	0.01	-0.24	-0.05
Retained Earnings	-682.44	-691.58	-723.45	-722.88	-623.56	-507.69
Shareholders' Equity	107.39	-0.46	-47.45	-85.75	-0.46	-7.77
Total Liabilities & Equity	158.25	120.53	201.79	260.89	339.41	358.66
Total Debt	5.6	9.39	13.97	18.06	18.06	21.68
Net Cash (Debt)	138.03	91.24	160.54	175.59	287.17	294.44
Net Cash Growth	51.29%	-43.17%	-8.58%	-38.85%	-2.47%	8.54%
Net Cash Per Share	1.18	1.08	2.17	2.67	4.48	6.38
Book Value	107.39	-0.46	-47.45	-85.75	-0.46	-7.77
Book Value Per Share	0.92	-0.01	-0.64	-1.30	-0.01	-0.17
Tangible Book Value	105.97	-1.99	-49.13	-87.58	-2.43	-9.89
Tangible Book Value Per Share	0.91	-0.02	-0.67	-1.33	-0.04	-0.21

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q